Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline

Sima Babaei,Mehri Haeili

doi:10.1186/s12879-021-06338-7

Abstract

BackgroundThe current emergence of multi-drug resistance among nosocomial pathogens has led to increased use of last-resort agents including Tigecycline (TGC). Availability of reliable methods for testing TGC susceptibility is crucial to accurately predict clinical outcomes. We evaluated the influence of different methodologies and type of media on TGC susceptibility of different gram-negative bacteria of clinical origin.MethodsThe TGC susceptibility of 84 clinical isolates of Klebsiella pneumoniae (n = 29), Escherichia coli (n = 30), and Acinetobacter baumannii (n = 25) was tested by broth microdilution (BMD), Etest, agar dilution (AD) and disk diffusion (DD) methods using Mueller Hinton agar from Difco and Mueller Hinton broth (MHB) from two different manufacturers (Difco and Condalab). FDA TGC susceptibility breakpoints issued for Enterobacteriaceae were used for interpretation of the results.ResultsMICs determined by BMD using MHB from two suppliers showed a good correlation with overall essential agreement (EA) and categorical agreement (CA) being 100% and 95% respectively. However, a twofold rise in BMD-Condalab MICs which was detected in 50% of the isolates, resulted in changes in susceptibility categories of few isolates with MICs close to susceptibility breakpoints leading to an overall minor error (MI) rate of 4.7%. Among the tested methods, Etest showed the best correlation with BMD, being characterized with the lowest error rates (only 1% MI) and highest overall EA (100%) and CA (98.8%) for all subsets of isolates. AD yielded the lowest overall agreement (EA 77%, CA 81%) with BMD in a species dependent manner, with the highest apparent discordance being found among the A. baumannii isolates. While the performance of DD for determination of TGC susceptibility among Enterobacteriaceae was excellent, (CA:100% with no errors), the CA was lower (84%) when it was used for A. baumannii where an unacceptably high minor-error rate was noted (16%). No major error or very major error was detected for any of the tested methods.ConclusionsEtest can be reliably used for TGC susceptibility testing in the three groups of studied bacteria. For the isolates with close-to-breakpoint MICs, testing susceptibility using the reference method is recommended.

Highlights

Tigecycline (TGC) is a new semisynthetic glycylcyclin with expanded-spectrum antibacterial activity against gram-negative and gram-positive bacteria [1]
agar dilution (AD) yielded the lowest overall agreement (EA 77%, categorical agreement (CA) 81%) with broth microdilution (BMD) in a species dependent manner, with the highest apparent discordance being found among the A. baumannii isolates
Etest can be reliably used for TGC susceptibility testing in the three groups of studied bacteria

Summary

Introduction

Tigecycline (TGC) is a new semisynthetic glycylcyclin with expanded-spectrum antibacterial activity against gram-negative and gram-positive bacteria [1]. It retains activity against most clinically significant multi-drug rein four hospitals located in different regions of Iran. Some of the tigecycline non-susceptible isolates were sistant (MDR) gram-negative bacteria (GNB) including extensively drug resistant A. baumannii [2] and carbapenem resistant Enterobacteriaceae (CRE) [3, 4]. The current emergence of multi-drug resistance among nosocomial pathogens has led to increased use of last-resort agents including Tigecycline (TGC). We evaluated the influence of different methodologies and type of media on TGC susceptibility of different gram-negative bacteria of clinical origin

Objectives

Methods

Results

Discussion

Conclusion